“The issue is suspected to be related with the variability of commercially available plated media, Haemophilus Test Medium, that are not manufactured or sold by BD, but are used in combination with our BD Sensi-Disc for testing,” the spokesperson said. More information can be found on an FDA dashboard post.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
